Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$5.53 - $10.84 $9.02 Million - $17.7 Million
-1,631,498 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$6.11 - $9.34 $228,825 - $349,792
37,451 Added 2.35%
1,631,498 $14.4 Million
Q4 2021

Feb 14, 2022

SELL
$6.74 - $22.31 $41.1 Million - $136 Million
-6,097,624 Reduced 79.28%
1,594,047 $11 Million
Q3 2021

Nov 15, 2021

SELL
$12.03 - $18.25 $3.35 Million - $5.08 Million
-278,505 Reduced 3.49%
7,691,671 $95.5 Million
Q2 2021

Aug 16, 2021

BUY
$18.09 - $22.42 $287,468 - $356,276
15,891 Added 0.2%
7,970,176 $145 Million
Q1 2021

May 17, 2021

BUY
$18.17 - $25.77 $29.2 Million - $41.4 Million
1,604,837 Added 25.28%
7,954,285 $166 Million
Q4 2020

Feb 16, 2021

BUY
$11.33 - $19.55 $71.9 Million - $124 Million
6,349,448 New
6,349,448 $113 Million

About Radius Health, Inc.


  • Ticker RDUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 47,620,500
  • Market Cap $480M
More about RDUS
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.